| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:177.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Departments of Anesthesiology and Critical Care Medicine (G.L., A.B., C.W.), Cardiology (M.M.), Vascular Surgery (Y.G.W., H.A., Y.B.), Cardio-thoracic Surgery (E.R., U.I.), and Nuclear Medicine (M.B.), Hebrew UniversityHadassah Medical Center, Jerusalem, Israel.
Correspondence to Giora Landesberg, MD, DSc, Department of Anesthesiology and Critical Care Medicine, Hadassah University Hospital, Ein-kerem, Kiryat-Hadassah, Jerusalem, Israel 91120. E-mail gio{at}cc.huji.ac.il
Background Ischemia on thallium scanning is a strong predictor of long-term mortality in CAD patients. Whether coronary revascularization (CR) in patients with significant ischemia on preoperative thallium scanning (PTS) improves long-term survival after major vascular surgery has not been determined.
Methods and Results The perioperative data, including PTS and subsequent CR in patients with moderate to severe reversible ischemia on PTS, and long-term survival of 502 consecutive patients who underwent 578 major vascular procedures were analyzed retrospectively. Patients with PTS who ultimately did not undergo the planned vascular operation were also studied. Cox regression and propensity score analyses were used to analyze survival. A total of 407 patients (81.1%) had PTS: 221 (54.3%) had no or mild defects (group I); 50 (12.3%) had moderate-severe fixed defects (group II); 62 (15.2%) had moderate-severe reversible ischemia yet did not undergo CR (group III); and 74 (18.2%) had moderate-severe reversible ischemia and subsequent CR by CABG (36) or PTCA (38; group IV). Patients who sustained major complications as a result of the preoperative cardiac workup were included in group IV. By multivariate analysis, age, type of vascular surgery, presence of diabetes, previous myocardial infarction, and moderate-severe ischemia on PTS independently predicted mortality (P=0.001, 0.009, 0.039, 0.006, and 0.029, respectively), and preoperative CR predicted improved survival (OR 0.52, P=0.018). Group IV had better survival than group III even when subdivided according to normal and reduced left ventricular function (OR 0.40 and 0.41, P=0.035 and 0.021, respectively).
Conclusions Long-term survival after major vascular surgery is significantly improved if patients with moderate-severe ischemia on PTS undergo selective CR.
Key Words: radioisotopes imaging revascularization survival surgery
This article has been cited by other articles:
![]() |
D. Poldermans, S. E. Hoeks, and H. H. Feringa Pre-Operative Risk Assessment and Risk Reduction Before Surgery J. Am. Coll. Cardiol., May 20, 2008; 51(20): 1913 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Kertai Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery: A Core Review Anesth. Analg., March 1, 2008; 106(3): 751 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y.W. Wong, H. P. Lawrence, and D. T. Wong The effects of prophylactic coronary revascularization or medical management on patient outcomes after noncardiac surgery - a meta-analysis: [Les effets de la revascularisation coronarienne prophylactique ou de la prise en charge medicale sur le devenir des patients apres une chirurgie non-cardiaque : une meta-analyse] Can J Anesth, September 1, 2007; 54(9): 705 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Boushra and M. Muntazar Review article: The role of statins in reducing perioperative cardiac risk: physiologic and clinical perspectives: [Le role des statines dans la reduction du risque cardiaque perioperatoire : perspectives physiologiques et cliniques]. Can J Anesth, November 1, 2006; 53(11): 1126 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bursi, L. Babuin, A. Barbieri, L. Politi, M. Zennaro, T. Grimaldi, A. Rumolo, M. Gargiulo, A. Stella, M. G. Modena, et al. Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation Eur. Heart J., November 2, 2005; 26(22): 2448 - 2456. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.J. Devereaux, L. Goldman, S. Yusuf, K. Gilbert, K. Leslie, and G. H. Guyatt Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review Can. Med. Assoc. J., September 27, 2005; 173(7): 779 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zimarino, A. M. Calafiore, and R. De Caterina Complete myocardial revascularization: between myth and reality Eur. Heart J., September 2, 2005; 26(18): 1824 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Priebe Perioperative myocardial infarction--aetiology and prevention Br. J. Anaesth., July 1, 2005; 95(1): 3 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Landesberg, M. Mosseri, L. A. Fleisher, J. Auer, G. Lamm, B. Eber, A. S. Brett, E. O. McFalls, H. B. Ward, T. Moritz, et al. Coronary Revascularization before Vascular Surgery N. Engl. J. Med., April 7, 2005; 352(14): 1492 - 1495. [Full Text] [PDF] |
||||
![]() |
G. Landesberg, M. Mosseri, V. Shatz, I. Akopnik, M. Bocher, M. Mayer, H. Anner, Y. Berlatzky, and C. Weissman Cardiac troponin after major vascular surgery: The role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization J. Am. Coll. Cardiol., August 4, 2004; 44(3): 569 - 575. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |